1. Home
  2. GLMD vs WLDS Comparison

GLMD vs WLDS Comparison

Compare GLMD & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • WLDS
  • Stock Information
  • Founded
  • GLMD 2000
  • WLDS 2014
  • Country
  • GLMD Israel
  • WLDS Israel
  • Employees
  • GLMD N/A
  • WLDS N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • WLDS Computer Communications Equipment
  • Sector
  • GLMD Health Care
  • WLDS Telecommunications
  • Exchange
  • GLMD Nasdaq
  • WLDS Nasdaq
  • Market Cap
  • GLMD 4.5M
  • WLDS 3.9M
  • IPO Year
  • GLMD 2014
  • WLDS 2022
  • Fundamental
  • Price
  • GLMD $2.70
  • WLDS $0.85
  • Analyst Decision
  • GLMD
  • WLDS
  • Analyst Count
  • GLMD 0
  • WLDS 0
  • Target Price
  • GLMD N/A
  • WLDS N/A
  • AVG Volume (30 Days)
  • GLMD 21.6K
  • WLDS 412.6K
  • Earning Date
  • GLMD 04-03-2025
  • WLDS 12-24-2024
  • Dividend Yield
  • GLMD N/A
  • WLDS N/A
  • EPS Growth
  • GLMD N/A
  • WLDS N/A
  • EPS
  • GLMD N/A
  • WLDS N/A
  • Revenue
  • GLMD N/A
  • WLDS $464,000.00
  • Revenue This Year
  • GLMD N/A
  • WLDS N/A
  • Revenue Next Year
  • GLMD N/A
  • WLDS N/A
  • P/E Ratio
  • GLMD N/A
  • WLDS N/A
  • Revenue Growth
  • GLMD N/A
  • WLDS 1500.00
  • 52 Week Low
  • GLMD $2.24
  • WLDS $0.73
  • 52 Week High
  • GLMD $23.80
  • WLDS $16.00
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 49.41
  • WLDS 37.54
  • Support Level
  • GLMD $2.24
  • WLDS $0.88
  • Resistance Level
  • GLMD $2.72
  • WLDS $0.95
  • Average True Range (ATR)
  • GLMD 0.20
  • WLDS 0.13
  • MACD
  • GLMD 0.02
  • WLDS 0.03
  • Stochastic Oscillator
  • GLMD 71.47
  • WLDS 22.12

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops a non-invasive Neural input interface for controlling digital devices using subtle finger movements. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

Share on Social Networks: